TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
Market News Page 12 of 232 • 5,786 articles
Alvotech og Advanz Pharma hefja sölu í Evrópu á fyrstu hliðstæðunni við Simponi
GlobeNewswire Inc. • Na
Alvotech og Advanz Pharma hefja sölu í Evrópu á fyrstu hliðstæðunni við Simponi

12/22/2025 02:00 AM • Alvotech announced the European market launch of Gobivaz, the first-ever biosimilar to Simponi (golimumab), through partner Advanz Pharma. NHS England selected Gobivaz following a competitive tender, supporting the health service's strategy to increase patient access to high-quality biopharmaceuticals. The drug is manufactured in Alvotech's Reykjavik facility.

ALVO - Alvotech achieved a significant milestone with the first-ever global market launch of a Simponi biosimilar, secured NHS England's competitive tender award, and is expanding European market presence with manufacturing capabilities in Iceland.
#biosimilar #Simponi #golimumab #Gobivaz #NHS England #European launch #Advanz Pharma #biopharmaceutical
Read More
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
GlobeNewswire Inc. • Alvotech
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

12/22/2025 02:00 AM • Alvotech announced the European launch of Gobivaz® (golimumab), the first-in-market biosimilar to Simponi® globally, commercialized by partner Advanz Pharma. The launch is supported by an NHS England tender award in the United Kingdom, which provides a defined framework for adoption within NHS services for treating immune-mediated inflammatory diseases.

ALVO - Alvotech achieved a significant milestone as the first company to launch a biosimilar to Simponi globally, secured NHS England tender award supporting market adoption, and demonstrated regulatory approval through comprehensive clinical studies. This represents successful commercialization and market validation.
#biosimilar #Simponi #golimumab #European launch #NHS England #Gobivaz #Advanz Pharma #first-in-market
Read More
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
GlobeNewswire Inc. • Alvotech
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

12/22/2025 02:00 AM • Alvotech announced the European launch of Gobivaz® (golimumab), the first-to-market biosimilar to Simponi® globally, commercialized by partner Advanz Pharma. The launch is supported by an NHS England tender award in the United Kingdom, which provides a defined framework for adoption within NHS services. Gobivaz is manufactured at Alvotech's Iceland facility and is available in the same presentations and dosage forms as the reference product.

ALVO - Alvotech achieved a significant milestone as the first company to launch a biosimilar to Simponi globally, secured NHS England tender award supporting market adoption, and demonstrated successful regulatory approval and manufacturing capabilities. This represents competitive advantage and revenue generation opportunity.
#biosimilar #Gobivaz #golimumab #Simponi #European launch #NHS England #Advanz Pharma #first-to-market #immune mediated inflammatory diseases
Read More
Skanska widens expressway in San Jacinto, California, USA, for USD 107M, about SEK 1.1 billion
Benzinga • Prnewswire
Skanska widens expressway in San Jacinto, California, USA, for USD 107M, about SEK 1.1 billion

12/22/2025 01:41 AM • Skanska has secured a USD 107 million contract with the Riverside County Transportation Commission to widen approximately 13 kilometers of the Ramona Expressway in San Jacinto, California. The project includes constructing a new bridge over the San Jacinto River, raising the median, and building a wildlife crossing. Work is expected to begin in February 2026 and be completed by June 2028.

SKBSY - Skanska secured a significant USD 107 million contract, which will be added to their US order bookings for Q4 2025. This represents new business revenue and demonstrates continued growth in their infrastructure construction portfolio in the United States.
#infrastructure #expressway expansion #construction contract #San Jacinto #California #bridge construction #wildlife habitat
Read More
Allied Gold Announces Commencement of Ore Processing at Sadiola’s Phase 1 Expansion, Progress on Capital Efficient Modular Phase 2 Expansion, and Update on Production for Q4
GlobeNewswire Inc. • Allied Gold Corporation
Allied Gold Announces Commencement of Ore Processing at Sadiola’s Phase 1 Expansion, Progress on Capital Efficient Modular Phase 2 Expansion, and Update on Production for Q4

12/21/2025 06:00 PM • Allied Gold has commenced operations of the Phase 1 expansion at its Sadiola mine in Mali, increasing fresh ore processing capacity from 20% to 60% of feed. The company expects Q4 2025 production of approximately 60,000 ounces at Sadiola and over 113,000 ounces overall, representing a 40% and 30% increase respectively over prior quarters. Phase 1 is expected to deliver annual production of 200,000-230,000 ounces (17-30% increase from 2023), with Phase 2 expansion planned for late 2026 to further boost production by 2029.

QSR - Mentioned as a parent company/subsidiary with no specific performance details in this announcement
AAUC - The company achieved a significant operational milestone by commencing Phase 1 expansion at Sadiola, which is expected to increase production by 17-30% and improve operational flexibility. Strong Q4 production guidance (113,000+ ounces overall, 40% increase at Sadiola) demonstrates solid operational performance. Phase 2 expansion planned for late 2026 with more capital-efficient modular design indicates continued growth trajectory and management confidence in the asset.
#Phase 1 expansion #ore processing #fresh ore comminution circuit #production guidance #Sadiola mine #Mali #Phase 2 expansion #gold production #capital efficiency #modular expansion
Read More
Could This AI Leader Be the Market's Best Performer Next Year?
The Motley Fool • Chris Neiger
Could This AI Leader Be the Market's Best Performer Next Year?

12/21/2025 05:45 PM • Micron Technology has surged 217% in 2025, significantly outpacing the S&P 500's 16% gains. The company reported strong Q1 fiscal 2026 results with 56% sales growth and 167% earnings growth, driven by massive AI data center spending. With DRAM memory prices expected to double in 2026 and Micron holding a 26% market share, the stock appears poised for continued growth. Notably, Micron trades at a P/E of 21, making it cheaper than most tech peers despite its exceptional performance.

MU - Strong quarterly results with 56% YoY sales growth and 167% earnings growth. Significant margin expansion to 56% with further increases expected. Positioned to benefit from surging AI data center spending. Attractive valuation at P/E of 21 compared to tech sector average of 44. DRAM prices expected to double in 2026, supporting continued growth.
#AI stocks #data center memory #DRAM #NAND flash memory #gross margins #valuation #earnings growth
Read More
Alphabet vs. Amazon: Which Stock Will Outperform in 2026?
The Motley Fool • Geoffrey Seiler
Alphabet vs. Amazon: Which Stock Will Outperform in 2026?

12/21/2025 05:32 PM • Alphabet significantly outperformed Amazon in 2025 by shifting investor perception through advances in its Gemini LLM and custom AI chips. However, the author predicts Amazon could outperform in 2026 as AWS accelerates growth, Trainium chips gain traction, and the company benefits from operating leverage in e-commerce and advertising. Both stocks trade at attractive valuations with solid growth prospects.

GOOG - Strong 2025 performance with ~60% stock gains driven by successful AI perception shift. Gemini LLM is now competitive, TPU chips are highly regarded, and the company has created a powerful flywheel effect combining top-tier AI chips with leading LLM technology.
#cloud computing #AI chips #Gemini LLM #AWS #TPU #Trainium #stock performance #valuation #e-commerce #data centers
Read More
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
GlobeNewswire Inc. • Telix Pharmaceuticals Limited
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

12/21/2025 04:38 PM • Telix Pharmaceuticals announced positive Phase 3 results for TLX591-CDx (Illuccix) in Chinese prostate cancer patients with a 94.8% positive predictive value, enabling near-term NDA submission in China. The company is also progressing with FDA resubmissions for TLX101-CDx (glioma imaging) and TLX250-CDx (renal cancer imaging), with collaborative meetings held to address manufacturing and control deficiencies.

TLX - Company achieved positive Phase 3 results for Illuccix in China with strong efficacy metrics (94.8% PPV), enabling regulatory submission in a strategically important market. FDA resubmissions for two additional candidates are progressing with collaborative alignment on remediation of deficiencies, indicating constructive regulatory engagement and pathway forward for multiple pipeline assets.
#precision medicine #radiopharmaceuticals #prostate cancer imaging #PSMA-PET #FDA resubmission #clinical trial #China market #glioma #renal cell carcinoma
Read More
Consumer Tech News (Dec 15-19): Meta Accelerates AI Wearables Push, Trump Unveils U.S. Air Taxi Strategy, US Halts Technology Agreement With UK & More
Benzinga • Lekha Gupta
Consumer Tech News (Dec 15-19): Meta Accelerates AI Wearables Push, Trump Unveils U.S. Air Taxi Strategy, US Halts Technology Agreement With UK & More

12/21/2025 03:43 PM • This week in consumer tech saw major developments across AI, transportation, and regulatory fronts. Meta is accelerating AI-powered wearables with updated smart glasses, while the Trump administration unveiled an air taxi strategy and launched Tech Force for recruiting tech talent. The U.S. halted a technology agreement with the UK, and Tesla faced a ruling that its Autopilot marketing was deceptive. OpenAI is in talks for a potential $10+ billion Amazon investment, and ChatGPT reached $3 billion in mobile app spending. Key earnings included Accenture and Micron beating estimates.

META - Accelerating AI-powered wearables with updated smart glasses and new AI models for image/video processing, positioning the company as a leader in premium AI hardware.
#AI wearables #air taxi strategy #technology agreement #Autopilot deception #OpenAI funding #ChatGPT spending #earnings #semiconductor demand
Read More
3 Brilliant High-Yield Dividend Stocks to Buy Now and Hold for the Long Term
The Motley Fool • Matt Dilallo
3 Brilliant High-Yield Dividend Stocks to Buy Now and Hold for the Long Term

12/21/2025 01:37 PM • Three REITs stand out for their exceptional dividend growth records and are recommended as long-term income investments. Realty Income has increased its dividend 133 times since 1994 with a 5.7% yield, Mid-America Apartment Communities has extended its dividend growth streak to 16 years with a 4.5% yield, and Rexford Industrial Realty has grown its dividend at 15% annually over five years with a 4.2% yield.

O - Company has demonstrated exceptional dividend consistency with 133 increases since 1994 and 113 consecutive quarters of increases. Strong financial profile with conservative 75% payout ratio, top-tier balance sheet, and substantial growth runway with $14 trillion in addressable market.
#dividend stocks #REITs #dividend growth #long-term investing #income stocks #real estate investment trusts
Read More
3 Must-Know Facts About Lululemon Before You Buy the Stock
The Motley Fool • Neil Patel
3 Must-Know Facts About Lululemon Before You Buy the Stock

12/21/2025 12:32 PM • Lululemon reported Q3 results beating Wall Street estimates with $2.6B revenue and $2.59 EPS. While the stock surged 22% in a month, the company faces significant headwinds: U.S. sales declined 3% amid weak consumer confidence, though China showed strong 46% growth. Despite a cheap forward P/E of 15.4, the company's growth outlook has slowed dramatically from 21.5% historical CAGR to projected 4.5% growth, and the CEO is stepping down.

LULU - Mixed signals: strong earnings beat and China expansion are positive, but U.S. sales decline (-3%), slowing growth projections (4.5% vs. historical 21.5%), CEO departure, and 59% decline from peak in Dec 2023 are concerning. Cheap valuation (P/E 15.4) offers some upside potential but reflects low market expectations.
#Lululemon #Q3 earnings #U.S. sales decline #China growth #consumer confidence #CEO transition #valuation #athleisure
Read More
Want to Invest in Quantum Computing? 3 Stocks That Are Great Buys Right Now
The Motley Fool • Will Healy
Want to Invest in Quantum Computing? 3 Stocks That Are Great Buys Right Now

12/21/2025 11:32 AM • The article recommends three established tech companies as quantum computing investment opportunities: Alphabet (Google) for its Willow quantum processor breakthrough in error correction, Intel for its Tunnel Falls quantum chip and turnaround under new leadership, and IBM for its Quantum Nighthawk 120-qubit computer and path to fault-tolerant systems by 2029. All three are positioned as safer alternatives to speculative quantum computing startups.

GOOG - Company has achieved quantum advantage with its Willow processor breakthrough in error correction, holds $98B in liquidity and $74B in free cash flow, trades at reasonable P/E ratio of 30 (near S&P 500 average), and stock up 60% in last 12 months with quantum computing expected to drive future revenue growth.
#quantum computing #Alphabet #Intel #IBM #Willow processor #Tunnel Falls #Quantum Nighthawk #error correction #technology stocks
Read More
BTDR REMINDER: Kessler Topaz Meltzer & Check, LLP Urges BTDR Investors with Losses to Contact the Firm
GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp
BTDR REMINDER: Kessler Topaz Meltzer & Check, LLP Urges BTDR Investors with Losses to Contact the Firm

12/21/2025 09:53 AM • A securities class action lawsuit has been filed against Bitdeer Technologies Group (NASDAQ: BTDR) for allegedly making materially false and misleading statements regarding its SEAL04 chip design progress and production timeline. The lawsuit covers investors who purchased Bitdeer securities between June 6, 2024, and November 10, 2025. The lead plaintiff deadline is February 2, 2026.

BTDR - The company is the subject of a securities class action lawsuit alleging material misrepresentations and omissions regarding chip design delays, production timeline issues, and false reassurances to investors about operational progress. These allegations indicate significant corporate misconduct and investor harm.
#securities class action #Bitdeer Technologies Group #SEAL04 chip #securities fraud #investor losses #misleading statements #lead plaintiff
Read More
Electric Toothbrush Market Size to Grow USD 9.37 Billion by 2033 | Report by SNS Insider
GlobeNewswire Inc. • Sns Insider
Electric Toothbrush Market Size to Grow USD 9.37 Billion by 2033 | Report by SNS Insider

12/21/2025 09:00 AM • The global electric toothbrush market is estimated at USD 5.10 billion in 2025 and projected to reach USD 9.37 billion by 2033, growing at a 7.90% CAGR. Growth is driven by rising dental disease rates, increased oral hygiene awareness, and adoption of advanced technologies. Battery-powered toothbrushes dominate with 62% market share, while female consumers represent 61% of the market. North America leads with 34% market share, while Asia Pacific shows strong growth potential. Key barriers include insufficient consumer awareness of product benefits.

PG - Listed as a leading market player in the growing electric toothbrush market with projected 7.90% CAGR through 2033, indicating strong market opportunity and revenue potential.
#electric toothbrush market #oral hygiene #dental health #market growth #consumer awareness #battery-powered toothbrushes #rechargeable toothbrushes #dental disease
Read More
Why Warren Buffett Just Sold 15% of His Apple Stake and Is Putting Money Here Instead
The Motley Fool • Stefon Walters
Why Warren Buffett Just Sold 15% of His Apple Stake and Is Putting Money Here Instead

12/21/2025 08:31 AM • Warren Buffett's Berkshire Hathaway sold 15% of its Apple stake in Q3 2025, reducing it to 20.9% of its portfolio. The company is instead parking over $305 billion in U.S. Treasury bills, earning around 3.66% annually. The moves reflect profit-taking ahead of potential tax rate changes and Apple's expensive valuation relative to growth expectations.

AAPL - Berkshire Hathaway reduced its Apple stake by 15%, citing expensive valuation with a forward P/E ratio of 34 (third-highest among Magnificent Seven stocks) relative to expected earnings growth. This signals reduced confidence in near-term returns.
#Warren Buffett #Berkshire Hathaway #Apple stock sale #Treasury bills #portfolio rebalancing #cash position #valuation concerns
Read More
SNPS COURT REMINDER: Synopsys, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before December 30
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
SNPS COURT REMINDER: Synopsys, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before December 30

12/21/2025 06:56 AM • A class action lawsuit has been filed against Synopsys, Inc. for securities fraud following a significant stock decline. The company allegedly misled investors about its Design IP segment's performance, concealing that customers required increasing customization that deteriorated business economics. After revealing the underperformance in Q3 2025 results, Synopsys stock dropped nearly 36% in one day. Investors have until December 30, 2025, to request lead plaintiff status.

NLYpI - High dividend yield is offset by significant risks including interest rate volatility, fluctuating earnings, inconsistent dividend payments, and high leverage (7.1x equity)
SNPS - The company is the subject of a securities fraud lawsuit alleging material misrepresentation regarding its Design IP business performance. The stock experienced a severe 36% single-day decline following the revelation of deteriorating business conditions that were previously undisclosed to investors.
#securities fraud #class action lawsuit #Design IP segment #stock decline #federal securities laws #investor disclosure
Read More
LRN COURT REMINDER: Stride, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 12
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
LRN COURT REMINDER: Stride, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 12

12/21/2025 06:54 AM • A class action lawsuit has been filed against Stride, Inc. for securities fraud, alleging the education technology company inflated enrollment numbers with 'ghost students' and misrepresented business growth. The stock dropped over 65% following two major disclosures in September and October 2025 about fraudulent practices and poor customer experience. Investors have until January 12, 2026, to join the lawsuit.

NLYpJ - High dividend yield is offset by significant risks including interest rate volatility, fluctuating earnings, inconsistent dividend payments, and high leverage (7.1x equity)
LRN - Company faces securities fraud allegations involving inflated enrollment numbers, compliance violations, and misrepresentation of business performance. Stock experienced catastrophic declines of 11% and 54% following fraud disclosures, with estimated impact of 10,000-15,000 fewer enrollments.
#securities fraud #class action lawsuit #Stride Inc. #enrollment fraud #ghost students #stock price decline #education technology #investor deadline
Read More
KMX COURT REMINDER: CarMax, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 2
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
KMX COURT REMINDER: CarMax, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 2

12/21/2025 06:51 AM • A class action securities fraud lawsuit has been filed against CarMax, Inc. and senior executives in the U.S. District Court for the District of Maryland. The suit alleges the company misrepresented demand for used cars, attributing strength to customer experience when tariff-driven pull-forward demand was the actual driver. CarMax stock dropped 20% on September 25, 2025, following disappointing Q2 results showing significant sales declines, and fell another 24% on November 6, 2025, following CEO Bill Nash's unexpected departure and weak Q3 guidance. Investors have until January 2, 2026, to request lead plaintiff status.

FNMA - Mentioned as an agency providing guarantees for mortgage-backed securities, with no specific investment recommendation
KMX - Company faces securities fraud allegations for misrepresenting demand drivers, experienced significant stock price declines (20% and 24% drops), reported disappointing financial results with broad-based sales declines across retail and wholesale segments, and experienced unexpected CEO departure with weak forward guidance.
#securities fraud #class action lawsuit #stock drop #tariffs #demand pull-forward #CEO departure #financial results decline #used car sales
Read More
JHX FINAL COURT REMINDER: James Hardie Industries plc Securities Fraud Deadline Approaching – Contact BFA Law before Tuesday’s December 23 Court Deadline
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
JHX FINAL COURT REMINDER: James Hardie Industries plc Securities Fraud Deadline Approaching – Contact BFA Law before Tuesday’s December 23 Court Deadline

12/21/2025 06:49 AM • A class action lawsuit has been filed against James Hardie Industries plc for securities fraud, alleging the company misrepresented North American fiber cement sales as sustainable customer demand when they were actually driven by inventory loading (channel stuffing). The company's stock fell over 34% on August 19, 2025, after revealing a 12% sales decline and expected continued destocking. Investors have until December 23, 2025, to request lead plaintiff status.

FMCC - Mentioned as an agency providing guarantees for mortgage-backed securities, with no specific investment recommendation
JHX - The company is facing a securities fraud class action lawsuit for allegedly misrepresenting sales figures through channel stuffing. Stock declined 34% after the truth was revealed, and the CFO resigned. The allegations indicate management deception regarding business performance and sustainability of sales.
#securities fraud #class action lawsuit #channel stuffing #inventory loading #fiber cement #stock decline #North American sales #destocking
Read More
ITGR COURT REMINDER: Integer Holdings Corporation Securities Fraud Deadline Approaching – Contact BFA Law before February 9
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
ITGR COURT REMINDER: Integer Holdings Corporation Securities Fraud Deadline Approaching – Contact BFA Law before February 9

12/21/2025 06:47 AM • A class action securities fraud lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) for allegedly overstating demand and revenue from its electrophysiology devices while publicly touting growth. The company disclosed lower 2025 guidance and admitted to slower-than-forecasted adoption of two EP devices on October 23, 2025, causing the stock to plummet 32%. Investors have until February 9, 2026, to join the case.

ITGR - The company is facing a securities fraud lawsuit for allegedly misrepresenting EP device demand and revenue. Stock dropped 32% following disclosure of significantly lowered guidance and admission of slower-than-forecasted product adoption, indicating serious operational and legal challenges.
#securities fraud #class action lawsuit #electrophysiology devices #guidance reduction #stock price decline #federal securities laws
Read More
INSP COURT REMINDER: Inspire Medical Systems, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 5
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
INSP COURT REMINDER: Inspire Medical Systems, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 5

12/21/2025 06:45 AM • A class action securities fraud lawsuit has been filed against Inspire Medical Systems, Inc. for allegedly misleading investors about the Inspire V device launch. The company failed to adequately prepare clinicians and payors, resulting in significant delays and weak demand. Inspire disclosed the issues on August 4, 2025, causing its stock to drop over 32% and reducing 2025 earnings guidance by more than 80%. Investors have until January 5, 2026, to join the lawsuit.

INSP - The company is facing a securities fraud lawsuit for allegedly misleading investors about product launch readiness. The stock dropped 32% following disclosure of launch delays, weak demand, and an 80% reduction in earnings guidance. The allegations indicate management failed to disclose material information about preparation gaps and demand issues.
#securities fraud #class action lawsuit #Inspire V launch #stock drop #earnings guidance reduction #medical device #sleep apnea
Read More
ARE COURT REMINDER: Alexandria Real Estate Equities, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 26
GlobeNewswire Inc. • Bleichmar Fonti & Auld Llp
ARE COURT REMINDER: Alexandria Real Estate Equities, Inc. Securities Fraud Deadline Approaching – Contact BFA Law before January 26

12/21/2025 06:43 AM • A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) for securities fraud following a 19% stock price drop on October 28, 2025. The company allegedly misrepresented its leasing volume and development pipeline, particularly regarding its Long Island City property, while experiencing lower occupancy rates and slower leasing activity. Alexandria Real Estate announced a $323.9 million real estate impairment charge and potential additional charges of $0-$685 million. Investors have until January 26, 2026, to join the lawsuit.

QSR - Mentioned as a parent company/subsidiary with no specific performance details in this announcement
ARE - The company faces securities fraud allegations for misrepresenting its financial condition and property performance. A significant 19% stock price drop, substantial impairment charges totaling $323.9 million with potential additional charges up to $685 million, and lower-than-expected occupancy rates and leasing activity indicate serious operational and legal challenges.
#securities fraud #class action lawsuit #real estate investment trust #impairment charge #stock price drop #Long Island City property #occupancy rates #leasing activity
Read More
Talent Acquisition Software Market to Surpass USD 51.16 Billion by 2032, Owing to AI-Powered Recruitment and Digital Hiring Transformation | Research by SNS Insider
GlobeNewswire Inc. • Sns Insider
Talent Acquisition Software Market to Surpass USD 51.16 Billion by 2032, Owing to AI-Powered Recruitment and Digital Hiring Transformation | Research by SNS Insider

12/21/2025 03:00 AM • The global Talent Acquisition Software Market is projected to grow from USD 25.69 billion in 2025 to USD 51.16 billion by 2032, driven by AI-powered recruitment, cloud-based solutions, and digital hiring transformation. The U.S. market alone is expected to double from USD 6.89 billion to USD 13.55 billion. Large enterprises currently dominate, while SMEs and the healthcare sector are expected to show the fastest growth.

NLYpG - High dividend yield is offset by significant risks including interest rate volatility, fluctuating earnings, inconsistent dividend payments, and high leverage (7.1x equity)
ORCL - Listed as a key player in the expanding talent acquisition software market, which is projected to grow at 9.10% CAGR through 2032
#talent acquisition software #AI-powered recruitment #cloud-based hiring #digital transformation #applicant tracking system #candidate relationship management #recruitment automation
Read More
Security Advisory Services Market Set to Hit USD 62.24 Billion by 2033, Driven by Rising Cyber Threat Complexity and Risk Management Needs | SNS Insider
GlobeNewswire Inc. • Sns Insider
Security Advisory Services Market Set to Hit USD 62.24 Billion by 2033, Driven by Rising Cyber Threat Complexity and Risk Management Needs | SNS Insider

12/21/2025 02:00 AM • The global security advisory services market is projected to grow from USD 19.41 billion in 2025 to USD 62.24 billion by 2033, with a CAGR of 15.69%. Growth is driven by rising cyber threats, regulatory compliance requirements, and increased enterprise demand for risk assessment and incident response services. The U.S. market alone is expected to grow from USD 5.26 billion to USD 16.57 billion by 2033. Penetration testing leads by service type, while large enterprises dominate adoption, with healthcare emerging as the fastest-growing industry segment.

NLYpF - High dividend yield is offset by significant risks including interest rate volatility, fluctuating earnings, inconsistent dividend payments, and high leverage (7.1x equity)
IBM - Listed as a key player in the expanding security advisory services market, positioned to benefit from growing demand for cybersecurity consulting and risk management services.
#cybersecurity advisory #security services market #cyber threats #risk management #penetration testing #CISO advisory #cloud security #compliance consulting #ransomware #digital transformation
Read More
Is a Beyond Meat (BYND) Stock Rally in the Cards in 2026?
The Motley Fool • Marc Guberti
Is a Beyond Meat (BYND) Stock Rally in the Cards in 2026?

12/20/2025 10:33 PM • Beyond Meat stock has crashed over 70% year-to-date despite a brief meme stock rally to $7.69 in October. The company faces significant headwinds including declining revenue across all segments, rising net operating losses, shrinking market share in a cooling plant-based meat industry, and waning consumer interest in ESG initiatives. While short squeeze potential exists, fundamentals suggest poor long-term investment prospects.

BYND - Company faces severe operational challenges including 21% U.S. revenue decline, 13.3% international revenue drop, increasing net operating losses ($34.9M excluding impairment charges), and declining market share in a contracting plant-based meat industry. Additionally, waning ESG interest and high product pricing relative to traditional meat create long-term sustainability concerns despite short-term meme stock volatility.
#Beyond Meat #plant-based meat #meme stock #declining revenue #ESG sentiment #market share loss #short squeeze #consumer sentiment
Read More